Icon ICLR reported solid second-quarter results highlighted by revenue exceeding $2 billion, representing an increase of 4% from the prior-year period. We have raised our fair value estimate to $243 ...
Icon's sound bolt-on acquisition strategy has built out a wide portfolio of capabilities, including imaging, central laboratory, all phases of clinical trials, staffing solutions, consulting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback